Sabby Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-81,161
| Closed | -$932K | – | 87 |
|
|
2018
Q4 | $932K | Sell |
81,161
-75,752
| -48% | -$870K | 0.21% | 16 |
|
|
2018
Q3 | $2.66M | Sell |
156,913
-11,326
| -7% | -$192K | 0.34% | 14 |
|
|
2018
Q2 | $2.39M | Buy |
168,239
+26,103
| +18% | +$371K | 0.37% | 17 |
|
|
2018
Q1 | $2.7M | Buy |
+142,136
| New | +$2.7M | 0.32% | 8 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 118 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 129 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 160 |
|
|
2017
Q1 | – | Sell |
-63,204
| Closed | -$193K | – | 180 |
|
|
2016
Q4 | $193K | Buy |
63,204
+30,400
| +93% | +$92.8K | 0.01% | 120 |
|
|
2016
Q3 | $152K | Buy |
+32,804
| New | +$152K | 0.01% | 129 |
|
|
2016
Q2 | – | Sell |
-134,500
| Closed | -$814K | – | 193 |
|
|
2016
Q1 | $814K | Buy |
134,500
+3,400
| +3% | +$20.6K | 0.04% | 99 |
|
|
2015
Q4 | $1.2M | Sell |
131,100
-304,125
| -70% | -$2.78M | 0.07% | 68 |
|
|
2015
Q3 | $2.46M | Buy |
435,225
+111,835
| +35% | +$631K | 0.1% | 53 |
|
|
2015
Q2 | $3.59M | Buy |
323,390
+63,649
| +25% | +$706K | 0.13% | 33 |
|
|
2015
Q1 | $4.07M | Sell |
259,741
-33,759
| -12% | -$529K | 0.17% | 25 |
|
|
2014
Q4 | $4.46K | Sell |
293,500
-126,623
| -30% | -$1.93K | 0.14% | 24 |
|
|
2014
Q3 | $4.53K | Sell |
420,123
-23,163
| -5% | -$250 | 0.17% | 16 |
|
|
2014
Q2 | $6.77M | Buy |
443,286
+266,021
| +150% | +$4.06M | 0.29% | 10 |
|
|
2014
Q1 | $3.21M | Buy |
+177,265
| New | +$3.21M | 0.18% | 20 |
|